{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:46:34Z","timestamp":1767707194908,"version":"3.38.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Translational Research Grant of NCRCH","award":["No.2021WWB02, No.2020ZKMB01"],"award-info":[{"award-number":["No.2021WWB02, No.2020ZKMB01"]}]},{"name":"Taishan Scholars Program of Shandong Province"},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["No. 2019QL018"],"award-info":[{"award-number":["No. 2019QL018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82270200, No.82070203"],"award-info":[{"award-number":["No.82270200, No.82070203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13754-4","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:45:58Z","timestamp":1740501958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune disease and risk of lymphoma: analysis from real-world data and Mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Linquan","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiange","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoya","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"5","key":"13754_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570\u201380.","journal-title":"Blood"},{"issue":"1","key":"13754_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"13754_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/030097401316909486","volume":"30","author":"MJ Leandro","year":"2001","unstructured":"Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy\u2013is there an association? Scand J Rheumatol. 2001;30(4):185\u20138.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"13754_CR4","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2352-3026(20)30126-5","volume":"7","author":"SA Atallah-Yunes","year":"2020","unstructured":"Atallah-Yunes SA, Murphy DJ, Noy A. HIV-associated Burkitt lymphoma. Lancet Haematol. 2020;7(8):e594\u2013600.","journal-title":"Lancet Haematol"},{"key":"13754_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","volume":"24","author":"E Baecklund","year":"2014","unstructured":"Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R. Lymphoma development in patients with autoimmune and inflammatory disorders\u2013what are the driving forces? Semin Cancer Biol. 2014;24:61\u201370.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"13754_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/aje\/kwv081","volume":"182","author":"P Hollander","year":"2015","unstructured":"Hollander P, Rostgaard K, Smedby KE, Chang ET, Amini RM, de Nully Brown P, Glimelius B, Adami HO, Melbye M, Glimelius I, et al. Autoimmune and atopic disorders and risk of classical Hodgkin Lymphoma. Am J Epidemiol. 2015;182(7):624\u201332.","journal-title":"Am J Epidemiol"},{"key":"13754_CR7","doi-asserted-by":"crossref","unstructured":"Kedra J, Seror R, Dieude P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L et al. Lymphoma complicating rheumatoid arthritis: results from a French case-control study. RMD Open. 2021;7(3).","DOI":"10.1136\/rmdopen-2021-001698"},{"issue":"18","key":"13754_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jnci\/djj361","volume":"98","author":"O Landgren","year":"2006","unstructured":"Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, Kerstann KF, Wheeler W, Hemminki K, Linet MS, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98(18):1321\u201330.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"13754_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/annonc\/mdu144","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol. 2014;25(7):1397\u2013404.","journal-title":"Ann Oncol"},{"issue":"5","key":"13754_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/rheumatology\/kel444","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, Boivin JF, Joseph L, Armitage J, Zoma A, et al. Hodgkin\u2019s lymphoma in systemic lupus erythematosus. Rheumatology (Oxford). 2007;46(5):830\u20132.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"13754_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.24287","volume":"125","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125(2):398\u2013405.","journal-title":"Int J Cancer"},{"issue":"1","key":"13754_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundstrom C, Akerman M, Melbye M, Glimelius B, et al. Autoimmune and chronic inflammatory disorders and risk of non-hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98(1):51\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"13754_CR13","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337\u201344.","journal-title":"Arch Intern Med"},{"key":"13754_CR14","doi-asserted-by":"publisher","first-page":"705079","DOI":"10.3389\/fimmu.2021.705079","volume":"12","author":"L Chatzis","year":"2021","unstructured":"Chatzis L, Goules AV, Stergiou IE, Voulgarelis M, Tzioufas AG, Kapsogeorgou EK. Serum, but not saliva, CXCL13 levels associate with infiltrating CXCL13\u2009+\u2009cells in the minor salivary gland lesions and other histologic parameters in patients with Sjogren\u2019s syndrome. Front Immunol. 2021;12:705079.","journal-title":"Front Immunol"},{"issue":"48","key":"13754_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/jncimonographs\/lgu010","volume":"2014","author":"JR Cerhan","year":"2014","unstructured":"Cerhan JR, Kricker A, Paltiel O, Flowers CR, Wang SS, Monnereau A, Blair A, Dal Maso L, Kane EV, Nieters A, et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr. 2014;2014(48):15\u201325.","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"8","key":"13754_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41408-018-0105-4","volume":"8","author":"G Kleinstern","year":"2018","unstructured":"Kleinstern G, Maurer MJ, Liebow M, Habermann TM, Koff JL, Allmer C, Witzig TE, Nowakowski GS, Micallef IN, Johnston PB, et al. History of autoimmune conditions and lymphoma prognosis. Blood Cancer J. 2018;8(8):73.","journal-title":"Blood Cancer J"},{"issue":"8","key":"13754_CR17","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstrom Smedby","year":"2008","unstructured":"Ekstrom Smedby K, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, et al. Autoimmune disorders and risk of non-hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029\u201338.","journal-title":"Blood"},{"issue":"6","key":"13754_CR18","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1172\/JCI78088","volume":"125","author":"MD Rosenblum","year":"2015","unstructured":"Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest. 2015;125(6):2228\u201333.","journal-title":"J Clin Invest"},{"issue":"6","key":"13754_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/aje\/kwu290","volume":"181","author":"SS Wang","year":"2015","unstructured":"Wang SS, Vajdic CM, Linet MS, Slager SL, Voutsinas J, Nieters A, de Sanjose S, Cozen W, Alarcon GS, Martinez-Maza O, et al. Associations of Non-hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol. 2015;181(6):406\u201321.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"13754_CR20","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"key":"13754_CR21","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner K, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA et al. FinnGen: unique genetic insights from combining isolated population and national health register data. 2022:2022.2003.2003.22271360."},{"issue":"5","key":"13754_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501.","journal-title":"Int J Epidemiol"},{"issue":"21","key":"13754_CR23","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926\u201340.","journal-title":"Stat Med"},{"key":"13754_CR24","doi-asserted-by":"publisher","first-page":"102945","DOI":"10.1016\/j.critrevonc.2020.102945","volume":"150","author":"S Khanmohammadi","year":"2020","unstructured":"Khanmohammadi S, Shabani M, Tabary M, Rayzan E, Rezaei N. Lymphoma in the setting of autoimmune diseases: a review of association and mechanisms. Crit Rev Oncol Hematol. 2020;150:102945.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"13754_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamaoncol.2021.5680","volume":"8","author":"MM He","year":"2022","unstructured":"He MM, Lo CH, Wang K, Polychronidis G, Wang L, Zhong R, Knudsen MD, Fang Z, Song M. Immune-mediated diseases Associated with Cancer risks. JAMA Oncol. 2022;8(2):209\u201319.","journal-title":"JAMA Oncol"},{"issue":"2","key":"13754_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00277-018-3515-2","volume":"98","author":"S Hu","year":"2019","unstructured":"Hu S, Zhou D, Wu Y, Zhao Y, Wang S, Han B, Duan M, Li J, Zhu T, Zhuang J, et al. Autoimmune disease-associated non-hodgkin\u2019s lymphoma-a large retrospective study from China. Ann Hematol. 2019;98(2):445\u201355.","journal-title":"Ann Hematol"},{"issue":"3","key":"13754_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54(3):692\u2013701.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"13754_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1093\/rheumatology\/ker143","volume":"50","author":"J Ji","year":"2011","unstructured":"Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford). 2011;50(8):1513\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"13754_CR29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/acr.21887","volume":"65","author":"SJ Johnsen","year":"2013","unstructured":"Johnsen SJ, Brun JG, Goransson LG, Smastuen MC, Johannesen TB, Haldorsen K, Harboe E, Jonsson R, Meyer PA, Omdal R. Risk of non-hodgkin\u2019s lymphoma in primary Sjogren\u2019s syndrome: a population-based study. Arthritis Care Res (Hoboken). 2013;65(5):816\u201321.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"13754_CR30","doi-asserted-by":"publisher","first-page":"683623","DOI":"10.3389\/fimmu.2021.683623","volume":"12","author":"A Nezos","year":"2021","unstructured":"Nezos A, Skarlis C, Psarrou A, Markakis K, Garantziotis P, Papanikolaou A, Gravani F, Voulgarelis M, Tzioufas AG, Koutsilieris M, et al. Lipoprotein-Associated Phospholipase A2: a Novel Contributor in Sjogren\u2019s syndrome-related lymphoma? Front Immunol. 2021;12:683623.","journal-title":"Front Immunol"},{"key":"13754_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","volume":"75","author":"A Klein","year":"2018","unstructured":"Klein A, Polliack A, Gafter-Gvili A. Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology. Leuk Res. 2018;75:45\u20139.","journal-title":"Leuk Res"},{"issue":"11","key":"13754_CR32","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1002\/ijc.27944","volume":"132","author":"JF Simard","year":"2013","unstructured":"Simard JF, Baecklund F, Chang ET, Baecklund E, Hjalgrim H, Olov Adami H, Glimelius B, Smedby KE. Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes. Int J Cancer. 2013;132(11):2659\u201366.","journal-title":"Int J Cancer"},{"issue":"2","key":"13754_CR33","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.clml.2017.11.009","volume":"18","author":"JL Koff","year":"2018","unstructured":"Koff JL, Rai A, Flowers CR. Characterizing autoimmune disease-associated diffuse large B-cell lymphoma in a SEER-Medicare Cohort. Clin Lymphoma Myeloma Leuk. 2018;18(2):e115\u201321.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"13754_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3324\/haematol.2017.176511","volume":"103","author":"SI Tracy","year":"2018","unstructured":"Tracy SI, Habermann TM, Feldman AL, Maurer MJ, Dogan A, Perepu US, Syrbu S, Ansell SM, Thompson CA, Weiner GJ, et al. Outcomes among north American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression. Haematologica. 2018;103(2):297\u2013303.","journal-title":"Haematologica"},{"issue":"4","key":"13754_CR35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2169\/internalmedicine.40.275","volume":"40","author":"K Eguchi","year":"2001","unstructured":"Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40(4):275\u201384.","journal-title":"Intern Med"},{"key":"13754_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000082106","volume":"8","author":"F Mackay","year":"2005","unstructured":"Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF\/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun. 2005;8:243\u201365.","journal-title":"Curr Dir Autoimmun"},{"issue":"11","key":"13754_CR37","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747\u201356.","journal-title":"J Exp Med"},{"issue":"3","key":"13754_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","volume":"19","author":"F Mackay","year":"2007","unstructured":"Mackay F, Silveira PA, Brink R. B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007;19(3):327\u201336.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"13754_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-3083.2005.01688.x","volume":"62","author":"P Szodoray","year":"2005","unstructured":"Szodoray P, Jonsson R. The BAFF\/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren\u2019s syndrome. Scand J Immunol. 2005;62(5):421\u20138.","journal-title":"Scand J Immunol"},{"issue":"8","key":"13754_CR40","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood-2004-02-0762","volume":"104","author":"AJ Novak","year":"2004","unstructured":"Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, et al. Expression of BLyS and its receptors in B-cell non-hodgkin lymphoma: correlation with disease activity and patient outcome. Blood. 2004;104(8):2247\u201353.","journal-title":"Blood"},{"issue":"11","key":"13754_CR41","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","volume":"15","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Baecklund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2069\u201377.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"13754_CR42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","volume":"264","author":"KE Smedby","year":"2008","unstructured":"Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas\u2013an update. J Intern Med. 2008;264(6):514\u201327.","journal-title":"J Intern Med"},{"issue":"2","key":"13754_CR43","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1182\/blood.V90.2.766","volume":"90","author":"B Royer","year":"1997","unstructured":"Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, Maloisel F, Clauvel JP, Brouet JC, Mariette X. Lymphomas in patients with Sjogren\u2019s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90(2):766\u201375.","journal-title":"Blood"},{"issue":"8","key":"13754_CR44","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjogren\u2019s syndrome. Arthritis Rheum. 1999;42(8):1765\u201372.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"13754_CR45","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","volume":"150","author":"E Rouvier","year":"1993","unstructured":"Rouvier E, Luciani MF, Mattei MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol. 1993;150(12):5445\u201356.","journal-title":"J Immunol"},{"issue":"5","key":"13754_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the Yin and the Yang. Trends Immunol. 2017;38(5):310\u201322.","journal-title":"Trends Immunol"},{"issue":"1","key":"13754_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3892\/br.2021.1438","volume":"15","author":"T Kanda","year":"2021","unstructured":"Kanda T, Yoshida A, Ogihara K, Minami H, Yamaguchi N, Ikebuchi Y, Nakao K, Isomoto H. Detection of cytokine storm in patients with achalasia using ELISA. Biomed Rep. 2021;15(1):62.","journal-title":"Biomed Rep"},{"issue":"6","key":"13754_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of Psoriasis. J Immunol. 2018;201(6):1605\u201313.","journal-title":"J Immunol"},{"key":"13754_CR49","doi-asserted-by":"crossref","unstructured":"Rafael-Vidal C, Perez N, Altabas I, Garcia S, Pego-Reigosa JM. Blocking IL-17: a promising strategy in the treatment of systemic rheumatic diseases. Int J Mol Sci. 2020;21(19).","DOI":"10.3390\/ijms21197100"},{"issue":"4","key":"13754_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","volume":"77","author":"S Glatt","year":"2018","unstructured":"Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawson ADG, Maroof A, Oliver R, Popa S, Strimenopoulou F, et al. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation. Ann Rheum Dis. 2018;77(4):523\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"13754_CR51","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925\u20136.","journal-title":"JAMA"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13754-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:16:48Z","timestamp":1740507408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13754"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13754-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethical Committee of Shandong Provincial Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"351"}}